Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Elagolix/estradiol/norethindrone acetate+elagolix - AbbVie

Next Previous
Drug Profile

Elagolix/estradiol/norethindrone acetate+elagolix - AbbVie

Alternative Names: Estradiol/elagolix/norethindrone acetate+elagolix – AbbVie; Estradiol/norethindrone acetate/elagolix+elagolix – AbbVie; Norethindrone acetate/elagolix estradiol+elagolix – AbbVie; Norethindrone acetate/estradiol/elagolix+elagolix – AbbVie; ORIAHNN

Latest Information Update: 13 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AbbVie
  • Class Acetates; Alcohols; Alkynes; Amines; Analgesics; Anisoles; Antineoplastics; Benzene derivatives; Carboxylic acids; Cyclohexenes; Estradiol congeners; Estrenes; Fluorinated hydrocarbons; Fluorobenzenes; Hormonal contraceptives; Hormonal replacements; Ketones; Norpregnenes; Oral contraceptives; Phenanthrenes; Pyrimidines; Small molecules
  • Mechanism of Action Estrogen receptor agonists; LHRH receptor antagonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Menorrhagia

Most Recent Events

  • 12 Mar 2026 Chemical structure information added.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top